517 related articles for article (PubMed ID: 32610077)
21. Flt3 inhibition alleviates chronic kidney disease by suppressing CD103+ dendritic cell-mediated T cell activation.
Wang R; Chen T; Wang C; Zhang Z; Wang XM; Li Q; Lee VWS; Wang YM; Zheng G; Alexander SI; Wang Y; Harris DCH; Cao Q
Nephrol Dial Transplant; 2019 Nov; 34(11):1853-1863. PubMed ID: 30590794
[TBL] [Abstract][Full Text] [Related]
22. FLT3-ligand treatment of humanized mice results in the generation of large numbers of CD141+ and CD1c+ dendritic cells in vivo.
Ding Y; Wilkinson A; Idris A; Fancke B; O'Keeffe M; Khalil D; Ju X; Lahoud MH; Caminschi I; Shortman K; Rodwell R; Vuckovic S; Radford KJ
J Immunol; 2014 Feb; 192(4):1982-9. PubMed ID: 24453245
[TBL] [Abstract][Full Text] [Related]
23. Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing.
Johansson-Lindbom B; Svensson M; Pabst O; Palmqvist C; Marquez G; Förster R; Agace WW
J Exp Med; 2005 Oct; 202(8):1063-73. PubMed ID: 16216890
[TBL] [Abstract][Full Text] [Related]
24. Subsets of CD1c
Heger L; Hofer TP; Bigley V; de Vries IJM; Dalod M; Dudziak D; Ziegler-Heitbrock L
Front Immunol; 2020; 11():559166. PubMed ID: 33101275
[TBL] [Abstract][Full Text] [Related]
25. CD163 positive subsets of blood dendritic cells: the scavenging macrophage receptors CD163 and CD91 are coexpressed on human dendritic cells and monocytes.
Maniecki MB; Møller HJ; Moestrup SK; Møller BK
Immunobiology; 2006; 211(6-8):407-17. PubMed ID: 16920480
[TBL] [Abstract][Full Text] [Related]
26. Inactivation of tumor-specific CD8⁺ CTLs by tumor-infiltrating tolerogenic dendritic cells.
Harimoto H; Shimizu M; Nakagawa Y; Nakatsuka K; Wakabayashi A; Sakamoto C; Takahashi H
Immunol Cell Biol; 2013 Oct; 91(9):545-55. PubMed ID: 24018532
[TBL] [Abstract][Full Text] [Related]
27. Id2 expression delineates differential checkpoints in the genetic program of CD8α+ and CD103+ dendritic cell lineages.
Jackson JT; Hu Y; Liu R; Masson F; D'Amico A; Carotta S; Xin A; Camilleri MJ; Mount AM; Kallies A; Wu L; Smyth GK; Nutt SL; Belz GT
EMBO J; 2011 May; 30(13):2690-704. PubMed ID: 21587207
[TBL] [Abstract][Full Text] [Related]
28. Distinct dendritic cell subsets dictate the fate decision between effector and memory CD8(+) T cell differentiation by a CD24-dependent mechanism.
Kim TS; Gorski SA; Hahn S; Murphy KM; Braciale TJ
Immunity; 2014 Mar; 40(3):400-13. PubMed ID: 24631155
[TBL] [Abstract][Full Text] [Related]
29. Serum lipids regulate dendritic cell CD1 expression and function.
Leslie DS; Dascher CC; Cembrola K; Townes MA; Hava DL; Hugendubler LC; Mueller E; Fox L; Roura-Mir C; Moody DB; Vincent MS; Gumperz JE; Illarionov PA; Besra GS; Reynolds CG; Brenner MB
Immunology; 2008 Nov; 125(3):289-301. PubMed ID: 18445008
[TBL] [Abstract][Full Text] [Related]
30. Dendritic cell differentiation potential of mouse monocytes: monocytes represent immediate precursors of CD8- and CD8+ splenic dendritic cells.
León B; Martínez del Hoyo G; Parrillas V; Vargas HH; Sánchez-Mateos P; Longo N; López-Bravo M; Ardavín C
Blood; 2004 Apr; 103(7):2668-76. PubMed ID: 14630812
[TBL] [Abstract][Full Text] [Related]
31. Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.
Salmon H; Idoyaga J; Rahman A; Leboeuf M; Remark R; Jordan S; Casanova-Acebes M; Khudoynazarova M; Agudo J; Tung N; Chakarov S; Rivera C; Hogstad B; Bosenberg M; Hashimoto D; Gnjatic S; Bhardwaj N; Palucka AK; Brown BD; Brody J; Ginhoux F; Merad M
Immunity; 2016 Apr; 44(4):924-38. PubMed ID: 27096321
[TBL] [Abstract][Full Text] [Related]
32. Expanded CD1c
Qiu G; Zhong S; Xie J; Feng H; Sun S; Gao C; Xu X; Kang B; Xu H; Zhao C; Ran L; Xinyu A; Xu B; Meng X; Meng L; Zhang X; Xiao L
J Immunol Res; 2022; 2022():9634073. PubMed ID: 35958878
[TBL] [Abstract][Full Text] [Related]
33. CD1c+ blood dendritic cells have Langerhans cell potential.
Milne P; Bigley V; Gunawan M; Haniffa M; Collin M
Blood; 2015 Jan; 125(3):470-3. PubMed ID: 25352125
[TBL] [Abstract][Full Text] [Related]
34. Granulocyte Macrophage-Colony Stimulating Factor Produces a Splenic Subset of Monocyte-Derived Dendritic Cells That Efficiently Polarize T Helper Type 2 Cells in Response to Blood-Borne Antigen.
Ryu SH; Shin HS; Eum HH; Park JS; Choi W; Na HY; In H; Kim TG; Park S; Hwang S; Sohn M; Kim ED; Seo KY; Lee HO; Lee MG; Chu MK; Park CG
Front Immunol; 2021; 12():767037. PubMed ID: 35069539
[TBL] [Abstract][Full Text] [Related]
35. Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens.
Tosi D; Valenti R; Cova A; Sovena G; Huber V; Pilla L; Arienti F; Belardelli F; Parmiani G; Rivoltini L
J Immunol; 2004 May; 172(9):5363-70. PubMed ID: 15100276
[TBL] [Abstract][Full Text] [Related]
36. Differential regulation of CD103 (αE integrin) expression in human dendritic cells by retinoic acid and Toll-like receptor ligands.
Roe MM; Swain S; Sebrell TA; Sewell MA; Collins MM; Perrino BA; Smith PD; Smythies LE; Bimczok D
J Leukoc Biol; 2017 May; 101(5):1169-1180. PubMed ID: 28087652
[TBL] [Abstract][Full Text] [Related]
37. CD8α
Kline DE; MacNabb BW; Chen X; Chan WC; Fosco D; Kline J
J Immunol; 2018 Dec; 201(12):3759-3769. PubMed ID: 30420437
[TBL] [Abstract][Full Text] [Related]
38. Luminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation.
Farache J; Koren I; Milo I; Gurevich I; Kim KW; Zigmond E; Furtado GC; Lira SA; Shakhar G
Immunity; 2013 Mar; 38(3):581-95. PubMed ID: 23395676
[TBL] [Abstract][Full Text] [Related]
39. Reprogramming tumor-infiltrating dendritic cells for CD103+ CD8+ mucosal T-cell differentiation and breast cancer rejection.
Wu TC; Xu K; Banchereau R; Marches F; Yu CI; Martinek J; Anguiano E; Pedroza-Gonzalez A; Snipes GJ; O'Shaughnessy J; Nishimura S; Liu YJ; Pascual V; Banchereau J; Oh S; Palucka K
Cancer Immunol Res; 2014 May; 2(5):487-500. PubMed ID: 24795361
[TBL] [Abstract][Full Text] [Related]
40. Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response.
Santodonato L; D'Agostino G; Nisini R; Mariotti S; Monque DM; Spada M; Lattanzi L; Perrone MP; Andreotti M; Belardelli F; Ferrantini M
J Immunol; 2003 May; 170(10):5195-202. PubMed ID: 12734367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
